Eguchi S, Huyashi J, Miyamura H, Watanabe H
Second Department of Surgery, Niigata University, Japan.
Kyobu Geka. 1995 Jul;48(8):708-15.
The long-term follow-up study was performed on various atrioventricular valvuloplasties, and our special technique of annuloplasty was also described. In mitral stenosis, 10 and 20 years actuarial survival rates were 82 and 78% in CMC and 92 and 83% in OMC with statistically better result. Reoperation free rates at 10 and 20 years were 86 and 74% in CMC, and 87 and 73% in OMC, although statistically better result was shown in OMC at 28 years. In mitral regurgitation, 140 patients underwent surgery from 1990 to 1994. MVP was successful on 33 patients and the remained 107 patients underwent MVR with St. Jude Medical valve. Actuarial survival rates at 5 and 10 years were 94 and 78% in MVP, and 92 and 88% in MVR. Complication free rates at these periods were 88 and 74% in MVP, and 78 and 69% in MVR, showing no statistical difference. In tricuspid regurgitation. 166 cases underwent DeVega's annuloplasty with excellent result of reoperation free rate of 97% at 10 years.
我们对各种房室瓣成形术进行了长期随访研究,并描述了我们特殊的瓣环成形术技术。在二尖瓣狭窄患者中,使用Carpentier-Edwards人工生物瓣(CMC)的10年和20年精算生存率分别为82%和78%,使用Omnicarbon人工生物瓣(OMC)的则为92%和83%,统计学上OMC的结果更好。CMC组10年和20年免于再次手术率分别为86%和74%,OMC组分别为87%和73%,不过在28年时OMC组的统计学结果更好。在二尖瓣反流患者中,1990年至1994年有140例患者接受了手术。33例患者进行二尖瓣修复术(MVP)成功,其余107例患者使用圣犹达医疗瓣膜进行二尖瓣置换术(MVR)。MVP组5年和10年精算生存率分别为94%和78%,MVR组分别为92%和88%。这些时期两组的无并发症发生率分别为:MVP组88%和74%,MVR组78%和69%,无统计学差异。在三尖瓣反流患者中,166例患者接受了DeVega瓣环成形术,10年免于再次手术率高达97%,效果极佳。